GSRX Industries Inc. (OTCQB: GSRX) utilizes a 54-slide investor update from January 2019 to detail its aggressive expansion into the cannabis and CBD markets. The strategy is bifurcated between high-end physical retail storefronts—branded as Green Spirit Rx in Puerto Rico and Pure & Natural in the US—and proprietary manufacturing through its majority-owned subsidiary, Spirulinex. The deck leans heavily on demographic data and real estate specifics to justify its location choices in affluent areas like Dorado, PR, and Lakeway, TX. While it provides clear evidence of narrowing losses per share…
Key takeaways
- The company operates under the OTCQB ticker GSRX as of the January 2019 update (Slide 1).
- Advisory board members include former government officials like Juan Bauzá Salas, Puerto Rico’s Secretary of Agriculture from 1986 to 1990 (Slide 7).
- Retail expansion targets affluent demographics, specifically citing an average household income of $162,319 within one mile of their Austin, TX location (Slide 13).
- Manufacturing efforts center on Spirulinex, which produces 'DragonGlass,' a patent-pending water-based dried activated THC and CBD powder (Slide 25).
- The Puerto Rico retail footprint includes a location in Dorado, described as one of the wealthiest communities on the island with a population near 40,000 (Slide 31).
- Market projections for Puerto Rico estimate a jump from $500 million in 2018 to $1.8 billion in 2019/2020, contingent on adult-use legalization (Slide 43).
- Financial performance shows a consistent reduction in loss per share, dropping from .21¢ in Q1 2018 to .04¢ in Q3 2018 (Slide 49).
- The deck utilizes a mix of operational updates for existing stores and 'awaiting final inspection' status for new sites like Isla Verde (Slide 37).
GSRX Industries Inc. Investor Presentation: January 2019 Update
GSRX Industries Inc. presents a comprehensive update on its operations as a publicly traded company on the OTCQB. The deck, totaling 54 slides (with 9 key slides analyzed here), serves as a progress report for shareholders and potential investors, focusing on the company's dual-track strategy: aggressive retail expansion in high-income territories and the development of proprietary cannabinoid delivery technologies.
Slide 1: Title and Branding
The cover slide establishes the company's identity with a clean, scientific aesthetic. The logo incorporates molecular structures, signaling a focus on the chemical and pharmaceutical aspects of cannabis rather than just lifestyle branding. It clearly identifies the company as GSRX Industries Inc. and notes its OTCQB: GSRX ticker symbol. The presentation is labeled as a January 2019 Update , positioning it as a timely report on recent milestones.
Slide 7: Board of Advisors
This slide focuses on building institutional credibility. Unlike many startup decks that highlight tech founders, GSRX emphasizes regulatory and security expertise. Juan Bauzá Salas is highlighted for his tenure as Puerto Rico’s Secretary of Agriculture and his 40 years of agricultural consulting. Luis F. Toledo-Bayouth brings 20 years of security experience, including time as a DEA Special Agent, which is a strategic inclusion for a cannabis company where security and compliance are paramount. Jeffrey B. Jump provides medical industry weight, having led a medical device company to $300 million in annual revenue. Alexander Zhilenkov is noted for his investment experience in oil, gas, and real estate.
Slide 13: Austin, Texas Retail Location
GSRX details its U.S. CBD retail strategy through the Pure & Natural brand. The slide provides a 'Demographic Snapshot' for a location in Lakeway, TX. The data is highly specific: a 1-mile average household income of $162,319 and a 5-mile population of 53,105 . The slide emphasizes 'excellent visibility' and a traffic count of 48,702 VPD (Vehicles Per Day) . This slide demonstrates a real-estate-first approach, treating CBD retail with the same demographic rigor as high-end traditional retail or pharmacy chains.
Slide 19: Clarksville, Tennessee Location
Continuing the retail expansion theme, this slide details a kiosk location in the Governor’s Square Mall . It lists a trade area population of 345,667 and an average income of $63,002 . By showing photos of neighboring tenants like Bath & Body Works, Zumiez, and American Eagle Outfitters, the company signals its intent to place CBD products in mainstream, high-traffic consumer environments. The mall itself is noted as being 1.1 million + sq. ft. , providing a sense of scale for the footprint.
Slide 25: Manufacturing and IP (Spirulinex)
This slide shifts from retail to intellectual property. GSRX identifies as the majority owner of Spirulinex, LLC , based in San Francisco. The core product is DragonGlass (a.k.a. Flake & Bake), described as a 'proprietary dried activated THC and CBD powder.' Key claims include that it is the 'world's first all-natural dried activated THC powder in combination with superfood.' The slide mentions a 'multitude of IP patent applications pending' and notes that the manufacturing headquarters in San Francisco's Green Zone was expected to be completed in Q1 2019 . This represents the company's vertical integration play.
Slide 31: Dorado, Puerto Rico Retail
The presentation moves to the Green Spirit Rx brand in Puerto Rico. The Dorado location is described as being in 'one of the wealthiest communities in Puerto Rico' near a Ritz-Carlton Reserve . The slide uses interior photos of a modern, clean dispensary and a map showing proximity to high-end resorts and golf courses. This reinforces the 'premium' market positioning mentioned in earlier slides.
Slide 37: Isla Verde, Puerto Rico Retail
The Isla Verde location is listed as 'Awaiting Final Inspection.' The slide highlights the area as the 'most popular beach vacation destination in all of Puerto Rico.' It cites a 'USA Travel readers' award from 2016 to validate the location's appeal. The inclusion of photos showing the store's interior—complete with modern green LED lighting and display cases—serves as proof of operational readiness, moving the project from a concept to a near-complete asset.
Slide 43: Puerto Rico Cannabis Growth Rates
This slide provides the macro-economic justification for the Puerto Rico expansion. It shows a bar chart where 2018 medical sales were $500M (based on 48k medical cards). It projects a massive increase to $1.8B in 2019/2020 , driven by an increase to 125k medical cards and the addition of 'Adult' use. A small footnote labels these as 'Guesstimates' and cites a third-party legal/news source. While the numbers are aggressive, the slide clearly defines the assumptions behind the growth.
Slide 49: Financial Performance - Loss Per Share
The final analyzed slide addresses the company's path to profitability. A bar chart titled 'GSRX Loss Per Share' shows a clear downward trend in losses throughout 2018. The loss per share was .21¢ in Q1 , .08¢ in Q2 , and .04¢ in Q3 . By presenting 'Actual' figures, the company attempts to show fiscal discipline and the positive impact of its scaling retail operations on the bottom line.
What GSRX Industries Does Well
GSRX excels at contextualizing its real estate . Instead of just listing addresses, they provide granular demographic data (income, traffic counts, neighboring tenants) that justifies why a specific storefront will succeed. This is a language that retail investors and REIT-style analysts understand well. Furthermore, the Board of Advisors slide is exceptionally strong for a cannabis company; by including a former Secretary of Agriculture and a former DEA agent, they proactively address the 'regulatory risk' question that plagues the industry.
The vertical integration story is also handled effectively. By separating the retail brands (Green Spirit Rx, Pure & Natural) from the IP/Manufacturing brand (Spirulinex), the company shows it is building a platform rather than just a chain of shops. The 'Loss Per Share' chart is a rare moment of transparency in an early-stage cannabis deck, showing a clear trajectory toward break-even.
What is Missing from the GSRX Deck
The most notable omission in these slides is detailed unit economics . While we see the loss per share narrowing, there is no data on the average revenue per square foot, customer acquisition costs, or the margin profile of the 'DragonGlass' product versus third-party wholesale goods. Investors are left to guess at the profitability of individual stores.
Additionally, the competitive landscape is entirely absent. In both the U.S. CBD market and the Puerto Rico medical market, GSRX was not the only player. The deck does not explain how Green Spirit Rx defends its territory against other dispensaries or how Spirulinex competes with other infusion technologies. Finally, the 'Ask' is not present in these slides; while it is an 'Update' deck, a clear statement of capital requirements for the next phase of expansion would have provided better closure.
Founder's Guide: What to Copy
Use Demographic Snapshots: If your business relies on physical locations, copy Slide 13. Don't just say 'we are in Austin.' Show the household income, the daytime population, and the traffic counts. It proves you have done the homework and aren't just picking locations based on 'vibes.'
Visual Proof of Progress: Slides 31 and 37 use high-quality photos of finished or near-finished interiors. For a company in a 'build-out' phase, showing that the lights are on and the shelves are built is more powerful than any 3D render. It reduces 'execution risk' in the mind of the investor.
Trend-Based Financials: If you are not yet profitable, copy the format of Slide 49. Showing a narrowing loss is the next best thing to showing a profit. It demonstrates that the business model is scaling and that fixed costs are being covered as revenue grows.
Strategic Advisory Alignment: Align your advisors with your biggest risks. GSRX knew their biggest risks were legal and agricultural, so they hired the Secretary of Agriculture and a DEA agent. Founders should identify their top three 'existential threats' and find advisors whose resumes specifically neutralize those threats.
Frequently asked questions
- What is GSRX's primary product differentiation in manufacturing?
- GSRX differentiates through its majority ownership of Spirulinex, LLC. According to Slide 25, they have developed 'DragonGlass' (also known as Flake & Bake), which is described as the world’s first all-natural dried activated THC powder combined with superfoods. This product is water-based, vegan, gluten-free, and zero-calorie, aimed at the sublingual and edible market using proprietary, patent-pending methods.
- How does the company select its retail locations?
- The company follows a 'high-end' retail strategy, targeting affluent areas with high visibility. For example, Slide 13 highlights an Austin location in Lakeway, TX, citing a $162,319 average household income and proximity to a major medical center. Similarly, Slide 31 focuses on Dorado, Puerto Rico, noting its status as a tourist favorite with five-star hotels and golf courses.
- What are the projected growth drivers for the Puerto Rico market?
- GSRX projects the Puerto Rico cannabis market will grow from $500 million to $1.8 billion. Slide 43 attributes this to an increase in medical cards (from 48k to 125k) and the anticipated opening of the 'Adult' (recreational) market. However, the slide explicitly labels these figures as 'Guesstimates' and notes they are sourced from third-party reports.
- What is the current financial trend for GSRX as of the deck's date?
- The financial trend shown in Slide 49 indicates a significant narrowing of losses. The 'Loss Per Share' chart shows a steady decline throughout 2018: starting at .21¢ in Q1, dropping to .08¢ in Q2, and reaching .04¢ by Q3. This suggests the company was moving toward break-even as its retail locations became operational.
- Who provides the regulatory and industry oversight for the company?
- GSRX relies on a Board of Advisors with deep local and industry expertise. Slide 7 lists Juan Bauzá Salas (former PR Secretary of Agriculture), Luis F. Toledo-Bayouth (former DEA Special Agent and security specialist), and Jeffrey B. Jump (a 39-year medical device industry veteran). This suggests a focus on compliance, security, and professional medical standards.
